https://de.marketscreener.com/kurs/aktie/SPEXIS-AG-43371335/news/Polyphor-einigt-sich-mit-FDA-auf-Studiendesign-fur-Murepavadin-27473673/?utm_source=telegram&utm_medium=social&utm_campaign=share